Published in Cell Mol Immunol on September 27, 2010
Baculovirus: an insect-derived vector for diverse gene transfer applications. Mol Ther (2013) 1.07
Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis. Mol Ther (2014) 0.82
Adaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo. J Virol (2013) 0.81
Inactivated Sendai virus strain Tianjin, a novel genotype of Sendai virus, inhibits growth of murine colon carcinoma through inducing immune responses and apoptosis. J Transl Med (2013) 0.79
Baculovirus-mediated gene delivery and RNAi applications. Viruses (2015) 0.79
Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy. Sci Rep (2016) 0.75
Baculovirus directly activates murine NK cells via TLR9. Cancer Gene Ther (2017) 0.75
A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 22.13
Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol (1987) 6.41
Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol (2004) 3.14
Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci U S A (1999) 2.55
FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res (2007) 2.21
Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J Immunol (1999) 1.89
Gene transfer as a tool to induce therapeutic vascular growth. Nat Med (2003) 1.85
Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol (2005) 1.64
Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol (2003) 1.57
Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology (1983) 1.50
Construction of an improved baculovirus insecticide containing an insect-specific toxin gene. Nature (1991) 1.46
Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. Cancer Res (2001) 1.43
Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol (2007) 1.25
Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein. Mol Ther (2007) 1.18
Dendritic cell vaccination and immune monitoring. Cancer Immunol Immunother (2008) 1.06
Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J Virol (2009) 1.05
Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol Ther (2007) 1.04
Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma. Hum Gene Ther (2001) 1.03
Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity. Mol Ther (2009) 1.00
Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity. J Immunol (2008) 0.99
Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene. J Immunol (2006) 0.98
Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol Ther (2007) 0.96
Retracted Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem Biophys Res Commun (2007) 0.95
Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications. Am J Pharmacogenomics (2003) 0.90
Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J Virol Methods (2008) 0.89
Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin). Exp Mol Med (2001) 0.87
Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells. Biochem Biophys Res Commun (2007) 0.86
Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery. Mol Ther (2010) 0.86
Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses. Cell Immunol (2009) 0.85
The Autographa californica nuclear polyhedrosis virus AcNPV induces functional maturation of human monocyte-derived dendritic cells. Vaccine (2006) 0.84
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine. Clin Cancer Res (2009) 0.82
Induction of antitumor acquired immunity by baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mice. Clin Vaccine Immunol (2007) 0.82
Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses. Tissue Antigens (2006) 0.80
Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol (2005) 1.64
Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G. EMBO J (2009) 1.63
Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol (2003) 1.57
Repressor of GATA negatively regulates murine contact hypersensitivity through the inhibition of type-2 allergic responses. Clin Immunol (2011) 1.44
Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol (2010) 1.39
The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses. Nat Immunol (2013) 1.21
Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Res (2002) 1.15
The biology of thymic stromal lymphopoietin (TSLP). Adv Pharmacol (2013) 1.12
Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3. J Biol Chem (2009) 1.08
Solution RNA structures of the HIV-1 dimerization initiation site in the kissing-loop and extended-duplex dimers. J Biochem (2005) 1.05
Short-hairpin RNAs synthesized by T7 phage polymerase do not induce interferon. Nucleic Acids Res (2008) 1.03
A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A (2003) 1.00
Interaction analysis between tmRNA and SmpB from Thermus thermophilus. J Biochem (2005) 0.97
Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells. J Virol (2013) 0.97
The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol (2012) 0.97
Genetic analysis of hepatitis C virus with defective genome and its infectivity in vitro. J Virol (2009) 0.96
Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol Ther (2007) 0.96
Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy. Int J Cancer (2006) 0.94
HIV/AIDS acquisition and transmission in Bangladesh: turning to the concentrated epidemic. Jpn J Infect Dis (2009) 0.93
Oncocytic adrenocortical carcinoma. Ann Diagn Pathol (2009) 0.92
Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL. Nucleic Acids Res (2005) 0.92
Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins. Virology (2010) 0.89
Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing. FEBS Lett (2010) 0.88
Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression. FEBS Lett (2008) 0.87
High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7. PLoS One (2013) 0.86
Solution structure of an RNA fragment with the P7/P9.0 region and the 3'-terminal guanosine of the tetrahymena group I intron. RNA (2002) 0.86
Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses. Cell Immunol (2009) 0.85
Laparoscopic cholecystectomy after coronary artery bypass grafting using the right gastroepiploic artery: report of a case. Surg Today (2002) 0.85
A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells. FEBS Lett (2004) 0.84
Characterization of baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mammalian cells. Biochem Biophys Res Commun (2006) 0.84
Cyclosporin A inhibits the propagation of influenza virus by interfering with a late event in the virus life cycle. Jpn J Infect Dis (2013) 0.82
Role of the zinc fingers of HIV-1 nucleocapsid protein in maturation of genomic RNA. J Biochem (2003) 0.82
Induction of antitumor acquired immunity by baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mice. Clin Vaccine Immunol (2007) 0.82
Individualized chemotherapy for colorectal cancer based on the collagen gel droplet-embedded drug sensitivity test. Oncol Lett (2012) 0.81
Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs. J Virol (2002) 0.81
Human immunodeficiency virus-1 Nef suppresses Hsp70-mediated Tat activation. FEBS Lett (2011) 0.81
Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator. Biochem Biophys Res Commun (2005) 0.81
2-aminophenoxazine-3-one suppresses the growth of mouse malignant melanoma B16 cells transplanted into C57BL/6Cr Slc mice. Biol Pharm Bull (2006) 0.81
Effective inhibition of HIV-1 replication in cultured cells by external guide sequences and ribonuclease P. Bioorg Med Chem Lett (2004) 0.80
Impact of age at marriage and migration on HIV and AIDS epidemics in Japan. Int J Equity Health (2009) 0.80
Evaluation of 5-fluorouracil applicability by multi-point collagen gel droplet embedded drug sensitivity test. Oncol Rep (2005) 0.80
Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy. J Surg Oncol (2006) 0.80
The interaction between human initiation factor eIF3 subunit c and heat-shock protein 90: a necessary factor for translation mediated by the hepatitis C virus internal ribosome entry site. Virus Res (2011) 0.80
Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells. Biochem Biophys Res Commun (2004) 0.80
Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice. J Allergy Clin Immunol (2006) 0.79
HIV-1 suppressive sequences are modulated by Rev transport of unspliced RNA and are required for efficient HIV-1 production. PLoS One (2012) 0.79
Structure and real-time monitoring of the enzymatic reaction of APOBEC3G which is involved in anti-HIV activity. Nucleic Acids Symp Ser (Oxf) (2009) 0.79
Inhibition of hepatitis C virus RNA replication by short hairpin RNA synthesized by T7 RNA polymerase in hepatitis C virus subgenomic replicons. Biochem Biophys Res Commun (2006) 0.79
Evaluation of 5-fluorouracil applicability by the collagen gel droplet embedded drug sensitivity test with area under the curve analysis. Anticancer Drugs (2007) 0.79
Inhibition of HIV-1 replication by an HIV-1 dependent ribozyme expression vector with the Cre/loxP (ON/OFF) system. Antivir Chem Chemother (2002) 0.79
NMR assignments and the identification of the secondary structure of the anti-retroviral cytidine deaminase. Nucleic Acids Symp Ser (Oxf) (2008) 0.79
Identification of amino acid residues in HIV-1 reverse transcriptase that are critical for the proteolytic processing of Gag-Pol precursors. FEBS Lett (2011) 0.79
RNAi expression mediated inhibition of HCV replication. Nucleic Acids Symp Ser (Oxf) (2004) 0.78
Suppression of hepatitis C virus core protein by short hairpin RNA expression vectors in the core protein expression Huh-7 cells. Nucleosides Nucleotides Nucleic Acids (2007) 0.78
Evaluation of the individual 50% inhibitory area under the concentration curve of 5-fluorouracil based on the collagen gel droplet embedded culture drug sensitivity test in colorectal cancer. Mol Med Rep (2011) 0.78
Heat shock protein 70 inhibits HIV-1 Vif-mediated ubiquitination and degradation of APOBEC3G. J Biol Chem (2011) 0.78
Good response to leucovorin and fluorouracil plus oxaliplatin and cetuximab therapy in a patient with metastatic ascending colon cancer harboring a KRAS p.G13D mutation. Oncol Lett (2011) 0.78
Intradermal immunization with combined baculovirus and tumor cell lysate induces effective antitumor immunity in mice. Int J Oncol (2013) 0.78
Inhibition of influenza virus by baculovirus-mediated shRNA. Nucleic Acids Symp Ser (Oxf) (2009) 0.78
HIV-1 Gag-virus-like particles induce natural killer cell immune responses via activation and maturation of dendritic cells. J Innate Immun (2011) 0.78
Evaluation of serum iron levels during FOLFOX4 and FOLFIRI therapies. Exp Ther Med (2010) 0.78
RNA interference targeted to the conserved dimerization initiation site (DIS) of HIV-1 restricts virus escape mutation. J Biochem (2009) 0.78
Inhibition of HIV-1 replication by long-term treatment with a chimeric RNA containing shRNA and TAR decoy RNA. Antiviral Res (2009) 0.78
Impact of orotate phosphoribosyl transferase activity as a predictor of lymph node metastasis in gastric cancer. Oncol Rep (2005) 0.77
Inhibition of hcv replication in HCV replicon by shRNAs. Nucleosides Nucleotides Nucleic Acids (2006) 0.77
HIV-1 RT-dependent DNAzyme expression inhibits HIV-1 replication without the emergence of escape viruses. Nucleic Acids Res (2010) 0.77
In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes. Antivir Chem Chemother (2004) 0.77
Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells. Biochem Biophys Res Commun (2006) 0.77
ZBRK1 represses HIV-1 LTR-mediated transcription. FEBS Lett (2012) 0.77
Leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan as individualized first-line therapy based on a drug sensitivity test. Exp Ther Med (2010) 0.77
RNA cleavage by a mammalian tRNA 3'processing endoribonuclease (3'tRNase) reduces HIV-1 expression. Nucleic Acids Res Suppl (2002) 0.77
A novel single-stranded DNA enzyme expression system using HIV-1 reverse transcriptase. Biochem Biophys Res Commun (2003) 0.77
Suppression of human immunodeficiency virus type 1 (HIV-1) replication by an HIV-1-dependent double locked vector with the Cre/loxP system. Nucleosides Nucleotides Nucleic Acids (2005) 0.77
Mechanism of drug resistance of hemagglutinin of influenza virus and potent scaffolds inhibiting its function. ACS Chem Biol (2012) 0.77
Effect of gastrectomy on the pharmacokinetics of 5-fluorouracil and gimeracil after oral administration of S-1. Anticancer Drugs (2006) 0.77
Inhibition of human immunodeficiency virus 1 replication in vitro by a self-stabilized oligonucleotide with 2'-O-methyl-guanosine-uridine quadruplex motifs. J Antimicrob Chemother (2003) 0.77
Suppression of HIV-1 replication by a combination of endonucleolytic ribozymes (RNase P and tRNnase ZL). Nucleosides Nucleotides Nucleic Acids (2006) 0.77
HIV gene therapy using RNA virus systems. Nucleic Acids Symp Ser (Oxf) (2006) 0.77
Combination therapy for hepatitis C virus with heat-shock protein 90 inhibitor 17-AAG and proteasome inhibitor MG132. Antivir Chem Chemother (2010) 0.77
Silencing of HIV-1 gene expression by two types of siRNA expression systems. Antivir Chem Chemother (2006) 0.76
PKC412 (CGP41251) modulates the proliferation and lipopolysaccharide-induced inflammatory responses of RAW 264.7 macrophages. Biochem Biophys Res Commun (2007) 0.76
Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy. Virol J (2009) 0.76
Induction of heat-shock protein 70 by prostaglandin A₁ inhibits HIV-1 Vif-mediated degradation of APOBEC3G. Antiviral Res (2013) 0.76
Evaluating the immune responses stimulated by CpG oligodeoxynucleotides. Nucleic Acids Res Suppl (2003) 0.76
Anti-tumor effect of intravenous TNFalpha gene delivery naked plasmid DNA using a hydrodynamics-based procedure. Nucleosides Nucleotides Nucleic Acids (2005) 0.76
Recognition of a bulged RNA by peptides derived from the influenza NS1 protein. J Biochem (2007) 0.76
Crucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis. PLoS One (2013) 0.76
Silencing of HIV-1 gene expression by siRNAs in transduced cells. Nucleosides Nucleotides Nucleic Acids (2006) 0.76
Suppression of HCV RNA replication by baculovirus-mediated shRNA expression. Nucleic Acids Symp Ser (Oxf) (2005) 0.76
HIV-1 Gag-virus-like particles inhibit HIV-1 replication in dendritic cells and T cells through IFN-α-dependent upregulation of APOBEC3G and 3F. J Innate Immun (2012) 0.75
Lack of interferon (IFN) response to T7 Transcribed pppG (n)(n = 2,3)-shRNA. Nucleosides Nucleotides Nucleic Acids (2007) 0.75
Baculovirus-mediated bispecific short-hairpin small-interfering RNAs have remarkable ability to cope with both influenza viruses A and B. Oligonucleotides (2009) 0.75
Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model. FEBS Lett (2002) 0.75
Evaluating target silencing by short hairpin RNA mediated by the group I intron in cultured mammalian cells. BMC Biotechnol (2011) 0.75
Long-term transgene expression and inhibition of HIV-1 replication by a Cre/loxP-EBNA-1/oriP HIV-1-dependent ribozyme vector: Applications for HIV-1 gene therapy. J RNAi Gene Silencing (2006) 0.75
The middle to 3' end of the HIV-1 vif gene sequence is important for vif biological activity and could be used for antisense oligonucleotide targets. Nucleosides Nucleotides Nucleic Acids (2005) 0.75
Usefulness of the perineum pusher in performing rectal procedures. Surg Today (2004) 0.75
Replication-defective HIV isolated from seronegative individuals at high risk for HIV infection. Nucleic Acids Symp Ser (Oxf) (2005) 0.75